OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
16.83
-0.76 (-4.32%)
At close: Aug 15, 2025, 3:47 PM

OptimizeRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
29.2M 21.93M 32.32M 21.31M 18.81M 19.69M 28.37M 16.33M 13.82M 13M 19.65M 15.09M 13.98M 13.73M 20.31M 16.12M 13.63M 11.23M
Cost of Revenue
10.56M 8.58M 10.29M 7.86M 7.11M 7.49M 10.53M 6.53M 5.99M 5.57M 7.2M 5.66M 4.99M 5.63M 7.92M 7.05M 5.58M 5.1M
Gross Profit
18.64M 13.34M 22.02M 13.45M 11.7M 12.2M 17.84M 9.8M 7.83M 7.43M 12.45M 9.42M 8.99M 8.1M 12.39M 9.08M 8.04M 6.12M
Operating Income
3.19M -2.11M 3.63M -8.56M -3.75M -5.03M -10.9M -3.55M -4.88M -7.06M -864.35K -3.76M -3.91M -3.76M 621.08K 38.19K 340.14K -638.31K
Interest Income
90K 88K 98K 107K 106K 20K 117.61K 688.19K 721K 665.47K 538.51K 289.97K 23.82K 3.00 2.38K 1.7K 11.96K 931.00
Pretax Income
1.71M -3.28M 2.21M -9.94M -5.1M -6.55M -11.74M -2.87M -4.16M -6.4M -325.84K -3.47M -3.88M -3.76M 623.46K 39.89K 352.1K -637.38K
Net Income
1.53M -2.2M -78K -9.12M -4.01M -6.9M -4.14M -2.87M -4.16M -6.4M 212.68K -3.18M -3.86M -3.76M 623.46K 39.89K 352.1K -637.38K
Selling & General & Admin
14.37M 14.36M 17.3M 13.43M 14.38M 16.17M 14.59M 12.89M 12.24M 14.03M 14.26M 12.14M 11.88M 11.39M 10.83M 8.08M 6.93M 5.92M
Research & Development
n/a 91K 71K 91K 71K 71K 143K 48K n/a 48K n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a 1M 1.02M 8.49M 1M 996K 14.02M 418.71K n/a n/a -938.46K 1.04M 1.02M 2.85M -488.14K 957.3K 772.56K 844.74K
Operating Expenses
14.37M 15.46M 18.39M 22.01M 15.45M 17.23M 28.74M 13.35M 12.71M 14.5M 13.32M 13.18M 12.9M 11.86M 11.77M 9.04M 7.7M 6.76M
Interest Expense
1.6M 1.3M 1.56M 1.52M 1.53M 1.55M 1.45M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -776.95K 200.68K 340.63K 36.12K 306.87K 337.78K 255.68K 128.88K
Cost & Expenses
26.01M 24.04M 28.68M 29.87M 22.56M 24.72M 39.27M 19.88M 18.7M 20.07M 20.52M 18.84M 17.89M 17.49M 19.69M 16.09M 13.29M 11.87M
Income Tax Expense
181K -1.08M 2.29M -817K -1.09M 344K -7.6M n/a 2.00 4.00 -538.51K -289.97K -23.82K -3 n/a n/a n/a n/a
Shares Outstanding (Basic)
18.51M 18.47M 18.42M 18.32M 18.26M 18.17M 18.16M 16.64M 16.99M 17.09M 17.07M 17.98M 18.12M 17.88M 17.64M 17.64M 17.35M 15.93M
Shares Outstanding (Diluted)
19.02M 18.47M 18.42M 18.32M 18.26M 18.17M 18.16M 16.64M 16.99M 17.09M 17.07M 17.98M 18.12M 17.88M 18.2M 18.2M 18.1M 16.1M
EPS (Basic)
0.08 -0.12 -0.00 -0.5 -0.22 -0.38 -0.23 -0.17 -0.24 -0.37 0.01 -0.18 -0.21 -0.21 0.04 0.00 0.02 -0.04
EPS (Diluted)
0.08 -0.12 -0.00 -0.5 -0.22 -0.38 -0.23 -0.17 -0.24 -0.37 0.01 -0.18 -0.21 -0.21 0.03 0.00 0.02 -0.04
EBITDA
4.39M -893K 4.87M -7.32M -2.5M -3.94M -9.28M -3.09M -3.7M -5.93M -407.8K -3.24M -3.33M -3.29M 1.1M 564.23K 340.14K -111.2K
EBIT
3.32M -1.99M 3.77M -8.42M -3.57M -5.01M -10.29M -3.55M -4.16M -6.4M -864.35K -3.76M -3.91M -3.76M 621.08K 38.19K 352.1K -637.38K
Depreciation & Amortization
1.07M 1.09M 1.09M 1.09M 1.07M 1.07M 1.01M 466.71K 464.76K 463.93K 456.55K 515.83K 578.12K 471.54K 506.28K 526.03K 527.96K 526.18K